236 related articles for article (PubMed ID: 29421308)
1. HMGB1-mediated DNA bending: Distinct roles in increasing p53 binding to DNA and the transactivation of p53-responsive gene promoters.
Štros M; Kučírek M; Sani SA; Polanská E
Biochim Biophys Acta Gene Regul Mech; 2018 Mar; 1861(3):200-210. PubMed ID: 29421308
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
[TBL] [Abstract][Full Text] [Related]
3. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
[TBL] [Abstract][Full Text] [Related]
4. The HMGB1 C-Terminal Tail Regulates DNA Bending.
Blair RH; Horn AE; Pazhani Y; Grado L; Goodrich JA; Kugel JF
J Mol Biol; 2016 Oct; 428(20):4060-4072. PubMed ID: 27558111
[TBL] [Abstract][Full Text] [Related]
5. Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.
McKinney K; Prives C
Mol Cell Biol; 2002 Oct; 22(19):6797-808. PubMed ID: 12215537
[TBL] [Abstract][Full Text] [Related]
6. The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage.
Magrini R; Russo D; Fronza G; Inga A; Menichini P
J Cell Biochem; 2007 Apr; 100(5):1276-87. PubMed ID: 17063487
[TBL] [Abstract][Full Text] [Related]
7. The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription.
Banerjee S; Kundu TK
Nucleic Acids Res; 2003 Jun; 31(12):3236-47. PubMed ID: 12799451
[TBL] [Abstract][Full Text] [Related]
8. HMGB1-facilitated p53 DNA binding occurs via HMG-Box/p53 transactivation domain interaction, regulated by the acidic tail.
Rowell JP; Simpson KL; Stott K; Watson M; Thomas JO
Structure; 2012 Dec; 20(12):2014-24. PubMed ID: 23063560
[TBL] [Abstract][Full Text] [Related]
9. Mouse double minute 2 associates with chromatin in the presence of p53 and is released to facilitate activation of transcription.
White DE; Talbott KE; Arva NC; Bargonetti J
Cancer Res; 2006 Apr; 66(7):3463-70. PubMed ID: 16585169
[TBL] [Abstract][Full Text] [Related]
10. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
[TBL] [Abstract][Full Text] [Related]
11. Borna disease virus phosphoprotein represses p53-mediated transcriptional activity by interference with HMGB1.
Zhang G; Kobayashi T; Kamitani W; Komoto S; Yamashita M; Baba S; Yanai H; Ikuta K; Tomonaga K
J Virol; 2003 Nov; 77(22):12243-51. PubMed ID: 14581561
[TBL] [Abstract][Full Text] [Related]
12. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
[TBL] [Abstract][Full Text] [Related]
13. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
14. Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its activity.
Kojic S; Nestorovic A; Rakicevic L; Protic O; Jasnic-Savovic J; Faulkner G; Radojkovic D
Arch Biochem Biophys; 2015 Mar; 569():45-53. PubMed ID: 25677450
[TBL] [Abstract][Full Text] [Related]
15. Activation of p53 function by human transcriptional coactivator PC4: role of protein-protein interaction, DNA bending, and posttranslational modifications.
Batta K; Kundu TK
Mol Cell Biol; 2007 Nov; 27(21):7603-14. PubMed ID: 17785449
[TBL] [Abstract][Full Text] [Related]
16. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
17. C-terminal region of human p53 attenuates buffalo p53 N-terminal-specific transactivation of p21 promoter by modulating tetramerization of the protein.
Singh M; Mukhopadhyay T
Mol Cell Biochem; 2018 Jun; 443(1-2):101-110. PubMed ID: 29147811
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes.
Lohrum M; Scheidtmann KH
Oncogene; 1996 Dec; 13(12):2527-39. PubMed ID: 9000127
[TBL] [Abstract][Full Text] [Related]
19. Cloning the genes and DNA binding properties of High Mobility Group B1 (HMGB1) proteins from the human blood flukes Schistosoma mansoni and Schistosoma japonicum.
de Oliveira FM; de Abreu da Silva IC; Rumjanek FD; Dias-Neto E; Guimarães PE; Verjovski-Almeida S; Stros M; Fantappié MR
Gene; 2006 Aug; 377():33-45. PubMed ID: 16644144
[TBL] [Abstract][Full Text] [Related]
20. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
